GLOFITAMAB

Approval Year

Name

Type

Language

GLOFITAMAB

Official Name

English

IMMUNOGLOBULIN G1 (149-GLUTAMIC ACID,215-GLUTAMIC ACID,461-ALANINE,462-ALANINE,556-GLYCINE,581-CYSTEINE,593-TRYPTOPHAN), ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL RG6026 VH-CH1 FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 10-AMINO ACID

Common Name

English

glofitamab [INN]

Common Name

English

RG-6026

Code

English

GLOFITAMAB [USAN]

Common Name

English

ANTI-CD20/CD3 BISPECIFIC MONOCLONAL ANTIBODY RO7082859

Common Name

English

RO7082859

Code

English

RO-7082859

Code

English

IMMUNOGLOBULIN G1-LAMBDA/KAPPA WITH DOMAIN CROSS-OVER, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)) MONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENTGAMMA-LAMBDA HEAVY CHAIN

Common Name

English

Glofitamab [WHO-DD]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

864121